Andre Delacourte
Overview
Explore the profile of Andre Delacourte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
4968
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Litvan I, Dickson D, Buttner-Ennever J, Delacourte A, Hutton M, Dubois B, et al.
Mov Disord
. 2017 May;
15(3):446-458.
PMID: 28470736
No abstract available.
2.
Melnyk P, Vingtdeux V, Burlet S, Eddarkaoui S, Grosjean M, Larchanche P, et al.
ACS Chem Neurosci
. 2015 Jan;
6(4):559-69.
PMID: 25611616
The amyloid precursor protein (APP) plays a central role in Alzheimer's disease (AD). Preventing deregulated APP processing by inhibiting amyloidogenic processing of carboxy-terminal fragments (APP-CTFs), and reducing the toxic effect...
3.
Dubois B, Feldman H, Jacova C, Cummings J, DeKosky S, Barberger-Gateau P, et al.
Lancet Neurol
. 2010 Oct;
9(11):1118-27.
PMID: 20934914
Alzheimer's disease (AD) is classically defined as a dual clinicopathological entity. The recent advances in use of reliable biomarkers of AD that provide in-vivo evidence of the disease has stimulated...
4.
Hudry E, Van Dam D, Kulik W, De Deyn P, Stet F, Ahouansou O, et al.
Mol Ther
. 2009 Aug;
18(1):44-53.
PMID: 19654569
The development of Alzheimer's disease (AD) is closely connected with cholesterol metabolism. Cholesterol increases the production and deposition of amyloid-beta (Abeta) peptides that result in the formation of amyloid plaques,...
5.
Caparros-Lefebvre D, Kerdraon O, Devos D, Dhaenens C, Blum D, Maurage C, et al.
Mov Disord
. 2009 Feb;
24(7):1089-90.
PMID: 19243029
No abstract available.
6.
Rudinskiy N, Grishchuk Y, Vaslin A, Puyal J, Delacourte A, Hirling H, et al.
J Biol Chem
. 2009 Feb;
284(18):12447-58.
PMID: 19240038
Clathrin-dependent endocytosis is mediated by a tightly regulated network of molecular interactions that provides essential protein-protein and protein-lipid binding activities. Here we report the hydrolysis of the alpha- and beta2-subunits...
7.
Thathiah A, Spittaels K, Hoffmann M, Staes M, Cohen A, Horre K, et al.
Science
. 2009 Feb;
323(5916):946-51.
PMID: 19213921
Deposition of the amyloid-beta peptide is a pathological hallmark of Alzheimer's disease. A high-throughput functional genomics screen identified G protein-coupled receptor 3 (GPR3), a constitutively active orphan G protein-coupled receptor,...
8.
Hebert S, Horre K, Nicolai L, Bergmans B, Papadopoulou A, Delacourte A, et al.
Neurobiol Dis
. 2008 Dec;
33(3):422-8.
PMID: 19110058
Gene dosage effects of Amyloid precursor protein (APP) can cause familial AD. Recent evidence suggest that microRNA (miRNA) pathways, implicated in gene transcriptional control, could be involved in the development...
9.
Delacourte A
J Alzheimers Dis
. 2008 Aug;
14(4):437-40.
PMID: 18688095
Most dementing disorders result from a degenerating process named tauopathy. Alzheimer disease is the most frequent one, but only one among the large spectrum of tau-related diseases. Cognitive impairment is...
10.